A case of S-100 negative melanoma: A diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin

被引:11
作者
Biernacka, Anna [1 ]
Linos, Konstantinos D. [1 ,3 ]
DeLong, Peter A. [2 ,3 ]
Suriawinata, Arief A. [1 ,3 ]
Padmanabhan, Vijayalakshmi [1 ,3 ]
Liu, Xiaoying [1 ,3 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Dept Pathol & Lab Med, One Med Ctr Dr, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Med Ctr, Dept Pulm Med, One Med Ctr Dr, Lebanon, NH 03766 USA
[3] Geisel Sch Med Dartmouth, Hanover, NH 03755 USA
关键词
Malignant melanoma; melanocytic-associated markers; poorly differentiated metastatic tumor of unknown origin; S-100; FINE-NEEDLE-ASPIRATION; MALIGNANT-MELANOMA; S100; MARKERS; BIOPSY;
D O I
10.4103/1742-6413.190914
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
When confronted with a metastatic poorly differentiated tumor of unknown origin, the initial workup includes the standard panel of immunostains to rule out carcinoma, sarcoma, lymphoma, and the greatest mimicker in pathology - malignant melanoma. Although not specific, the S-100 protein is expressed in over 95% of malignant melanomas. Herein, we present a case of multiorgan metastatic malignancy with a dominant hilar and mediastinal mass in a current smoker; clinically, highly suggestive of widespread primary lung cancer. This case was eventually classified as malignant melanoma, despite a significant diagnostic challenge due to lack of prior history, unusual cytomorphology, and S-100 protein negativity. A battery of immunostains was performed and the addition of other melanocytic-associated markers confirmed the melanocytic lineage of the neoplasm. This case highlights the pitfalls in the differential diagnosis of a metastatic tumor of unknown origin by fine needle aspiration cytology due to the significant morphologic overlap of poorly differentiated malignancies. We emphasize that, albeit rare, malignant melanomas can be completely negative for S-100 protein and the use of additional melanocytic-associated markers in the differential workup maybe critical in arriving promptly at a proper diagnosis. We also briefly discuss other currently available immunohistochemical markers that can assist in the identification of the S-100 negative melanoma.
引用
收藏
页数:7
相关论文
共 23 条
[1]   S-100 PROTEIN NEGATIVE MALIGNANT-MELANOMA - FACT OR FICTION - A LIGHT-MICROSCOPIC AND IMMUNOHISTOCHEMICAL STUDY [J].
ARGENYI, ZB ;
CAIN, C ;
BROMLEY, C ;
VANNGUYEN, A ;
ABRAHAM, AA ;
KERSCHMANN, R ;
LEBOIT, PE .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1994, 16 (03) :233-240
[2]   AN IMMUNOPHENOTYPIC SURVEY OF MALIGNANT MELANOMAS [J].
BISHOP, PW ;
MENASCE, LP ;
YATES, AJ ;
WIN, NA ;
BANERJEE, SS .
HISTOPATHOLOGY, 1993, 23 (02) :159-166
[3]   Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors [J].
Chang, KL ;
Folpe, AL .
ADVANCES IN ANATOMIC PATHOLOGY, 2001, 8 (05) :273-275
[4]  
de Vries TJ, 2001, J PATHOL, V193, P13
[5]  
Gatta LB, 2012, EUR J HISTOCHEM, V56, P63, DOI [10.4081/ejh.2012.e12, 10.4081/ejh.2012.12]
[6]  
GAYNOR R, 1981, LANCET, V1, P869
[7]   Fine-Needle Aspiration Cytology for the Diagnosis of Metastatic Melanoma Systematic Review and Meta-Analysis [J].
Hall, Brian J. ;
Schmidt, Robert L. ;
Sharma, Rohit R. ;
Layfield, Lester J. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (05) :635-642
[8]  
KANMITCHELL J, 1990, INVEST OPHTH VIS SCI, V31, P1492
[9]   Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells [J].
Lin, J ;
Yang, QY ;
Yan, Z ;
Markowitz, J ;
Wilder, PT ;
Carrier, F ;
Weber, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :34071-34077
[10]  
Marchevsky AM, 2010, ARCH PATHOL LAB MED, V134, P194, DOI 10.1043/1543-2165-134.2.194